Bacterial strains for medical uses
AssigneeOspedale San Raffaele S.R.L.
InventorsMatteo Maria Salvatore BELLONE, Arianna BREVI, Arianna CALCINOTTO, Roberto FERRARESE, Filippo CANDUCCI
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of bacterial strain to be used in medicine. In particular, it relates to the prevention and/or treatment of cancer or diabetes, bacterial strain is Prevotella melaninogenica.
Claims23
(canceled)
A method to prevent and/or to block the migration of Il-17 producing cells, preferably to prevent and/or to block the migration of Il-17 producing cells from the gut to the bone marrow, comprising administering a bacterial strain of Prevotella melaninogenica or a part thereof to a patient in need thereof.
(canceled)
A method for the treatment and/or prevention of cancer or diabetes, preferably Type 1 diabetes, comprising administering a bacterial strain of Prevotella melaninogenica or a part thereof to a patient in need thereof.
A method for the treatment and/or prevention of a condition associated with IL-17 and/or eosinophils, comprising administering a bacterial strain of Prevotella melaninogenica or a part thereof to a patient in need thereof.
(canceled)
(canceled)
(canceled)
A method for the prognosis of cancer, comprising the steps of:
- a) measuring the amount of IL-17 in a biological sample isolated from a subject;
- and
- b) comparing said measured IL-17 level to a control IL-17 amount.
Dependencies are inferred from the claim text.